luteolin Report issue

Small molecule Experimental
AACT PubChem

Active Ingredient History

NOW
  • Now
Progesterone (P4), sold under the brand name Prometrium among others, is a medication and naturally occurring steroid hormone. It is a progestogen and is used in combination with estrogens mainly in hormone therapy for menopausal symptoms and low sex hormone levels in women. It is also used in women to support pregnancy and fertility and to treat gynecological disorders. Progesterone can be taken by mouth, vaginally, and by injection into muscle or fat, among other routes. A progesterone vaginal ring and progesterone intrauterine device used for birth control also exist in some areas of the world.   Wikipedia

Chemistry

  • SMILES: O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
  • InChIKey: IQPNAANSBPBGFQ-UHFFFAOYSA-N
  • Mol. Mass: 286.24
  • ALogP: 2.28
  • ChEMBL Molecule:
    luteolin  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

luteol | luteolin

Organizations (15)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (5)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Alzheimer Disease (Phase 1)

Autism Spectrum Disorder (Phase 2)

Carcinoma (Early Phase 1)

Gulf War (Phase 2)

Tongue Neoplasms (Early Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 11
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue